BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2837049)

  • 1. Experimental studies of photodynamic therapy in a retinoblastoma-like tumour.
    Winther J; Overgaard J
    Acta Ophthalmol Suppl (1985); 1987; 182():140-3. PubMed ID: 2837049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of photodynamic therapy on a retinoblastoma-like tumour. An experimental in vitro and in vivo study on the potential use of photodynamic therapy in the treatment of retinoblastoma.
    Winther JB
    Acta Ophthalmol Suppl (1985); 1990; (197):1-37. PubMed ID: 2176429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy of experimental intraocular retinoblastomas--dose-response relationships to light energy and photofrin II.
    Winther J; Overgaard J
    Acta Ophthalmol (Copenh); 1989 Feb; 67(1):44-50. PubMed ID: 2528265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy effect in an intraocular retinoblastoma-like tumour assessed by an in vivo to in vitro colony forming assay.
    Winther J
    Br J Cancer; 1989 Jun; 59(6):869-72. PubMed ID: 2525401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of photodynamic therapy alone and in combination with misonidazole or X-rays for management of a retinoblastoma-like tumour.
    Winther J; Overgaard J; Ehlers N
    Photochem Photobiol; 1988 Mar; 47(3):419-23. PubMed ID: 2967981
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of photofrin II and light energy on retinoblastoma-like cells in vitro. Dose-response relationships, effect of light dose rate and recovery ratio.
    Winther J
    J Cancer Res Clin Oncol; 1989; 115(1):73-8. PubMed ID: 2522095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the in vivo and in vitro photosensitizing capabilities of uroporphyrin I compared to photofrin II.
    Nelson JS; Sun CH; Berns MW
    Lasers Surg Med; 1986; 6(2):131-6. PubMed ID: 2941630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The photodynamic effects of photofrin II, hematoporphyrin derivative, hematoporphyrin, and tetrasodium-mesotetra(4-sulfonatophenyl)porphine in vitro: clonogenic cell survival and drug uptake studies.
    West CM; Moore JV
    Photochem Photobiol; 1989 Feb; 49(2):169-74. PubMed ID: 2523543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution of indium 111-labeled dihematoporphyrin ether in papillomas and body tissues. Relevance to photodynamic therapy.
    Shikowitz MJ; Galli R; Bandyopadhyay D; Hoory S
    Arch Otolaryngol Head Neck Surg; 1989 Jul; 115(7):845-7. PubMed ID: 2525396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitization of tumours by porphyrins.
    Luksiene Z; Juzenas P; Moan J
    Cancer Lett; 2006 Apr; 235(1):40-7. PubMed ID: 15946797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue distribution of 3H-hematoporphyrin derivative in athymic "nude" mice heterotransplanted with human retinoblastoma.
    Gomer CJ; Rucker N; Mark C; Benedict WF; Murphree AL
    Invest Ophthalmol Vis Sci; 1982 Jan; 22(1):118-20. PubMed ID: 7056618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor regression of human retinoblastoma in the nude mouse following photoradiation therapy: a preliminary report.
    Benedict WF; Lingua RW; Doiron DR; Dawson JA; Murphree AL
    Med Pediatr Oncol; 1980; 8(4):397-401. PubMed ID: 7453671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy of C3H mouse mammary carcinoma with haematoporphyrin di-ethers as sensitizers.
    Evensen JF; Sommer S; Rimington C; Moan J
    Br J Cancer; 1987 May; 55(5):483-6. PubMed ID: 2955805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological changes in an intraocular retinoblastoma-like tumour following photodynamic therapy.
    Winther J; Ehlers N
    Acta Ophthalmol (Copenh); 1988 Feb; 66(1):69-78. PubMed ID: 3364172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model.
    Henderson BW; Fingar VH
    Photochem Photobiol; 1989 Mar; 49(3):299-304. PubMed ID: 2525260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy.
    Gossner L; Wittke H; Warzecha A; Sroka R; Ernst H; Meier M; Ell C
    Br J Cancer; 1991 Jul; 64(1):84-6. PubMed ID: 1830212
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison on the biological activity of three home-made HpDs with that of photofrin II].
    Han R; Xu CX; Li ZR; Cheng YS; Du CZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Jun; 8(3):159-64. PubMed ID: 2946453
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic ratio of photodynamic therapy in the treatment of superficial tumours of skin and subcutaneous tissues in man.
    Gilson D; Ash D; Driver I; Feather JW; Brown S
    Br J Cancer; 1988 Nov; 58(5):665-7. PubMed ID: 2975499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular effects of photodynamic therapy in an intraocular retinoblastoma-like tumour.
    Horsman MR; Winther J
    Acta Oncol; 1989; 28(5):693-7. PubMed ID: 2590545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake and photodynamic efficiency of hematoporphyrin, hydroxyethylvinyldeuteroporphyrin and hematoporphyrin derivative (Photofrin II): a study with isolated mitochondria.
    Dellinger M; Vever-Bizet C; Brault D; Moreno G; Salet C
    Photochem Photobiol; 1990 Feb; 51(2):185-9. PubMed ID: 2139729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.